These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 10597730)

  • 41. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunobiology of carcinoma of the prostate.
    Catalona WJ
    Invest Urol; 1980 Mar; 17(5):373-7. PubMed ID: 6987190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular insights into the development of T cell-based immunotherapy for prostate cancer.
    Dong B; Minze LJ; Xue W; Chen W
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1547-57. PubMed ID: 25259804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current aspects of tumor immunology. Preface and introduction.
    Weiss DW
    Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunologic approaches to the treatment of prostate cancer.
    Harris DT; Matyas GR; Gomella LG; Talor E; Winship MD; Spitler LE; Mastrangelo MJ
    Semin Oncol; 1999 Aug; 26(4):439-47. PubMed ID: 10482186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung cancer immunotherapy.
    Raez LE; Fein S; Podack ER
    Clin Med Res; 2005 Nov; 3(4):221-8. PubMed ID: 16303887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific and non-specific responses in host resistance to tumors.
    Baldwin RW
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):419-28. PubMed ID: 6398929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BCG adjuvant immunotherapy in carcinoma of the prostate: an interim report.
    Guinan PD; John T; Nagale V; Ablin RJ
    Allergol Immunopathol (Madr); 1978; 6(4):293-6. PubMed ID: 735980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New possibilities for cancer therapy with advances in cancer immunology.
    MacLean GD; Longenecker BM
    Can J Oncol; 1994 Apr; 4(2):249-54. PubMed ID: 7516257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer vaccines: reborn or just recycled?
    Berd D
    Semin Oncol; 1998 Dec; 25(6):605-10. PubMed ID: 9865675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG.
    Guinan PD; John T; Sahadevan V; Crispen R; Nagale V; McKiel C; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):355-60. PubMed ID: 748793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cancer immunotherapy: immunologic bases, reality and hopes].
    Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
    Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biologic and immunologic therapy of ovarian cancer.
    Bookman MA; Berek JS
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):941-65. PubMed ID: 1500395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunotherapy of colorectal cancers].
    Bécouarn Y; Seitz JF; Perrier H; Rouhier ML; Giovannini M; Brunet R
    Gastroenterol Clin Biol; 1996 Feb; 20(1):20-32. PubMed ID: 8734308
    [No Abstract]   [Full Text] [Related]  

  • 58. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunotherapy for prostate cancer: what's the future?
    Arlen PM; Dahut WL; Gulley JL
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):965-83, xi. PubMed ID: 16861126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.